Entheon Biomedical Corp (ENBI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 02-2023 | 11-2022 | 08-2022 | 05-2022 | 02-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 491 | 680 | 248 | 468 | 821 |
| Receivables | 83 | 42 | 45 | 30 | 23 |
| Inventories | 14 | 0 | 15 | 16 | 28 |
| TOTAL | $646 | $744 | $587 | $1,109 | $1,733 |
| Non-Current Assets | |||||
| PPE Net | N/A | 0 | 149 | 160 | 176 |
| Investments And Advances | N/A | 0 | 530 | 565 | 683 |
| Intangibles | N/A | 0 | 5,424 | 5,570 | 5,730 |
| Other Non-Current Assets | 25 | 25 | 0 | 0 | 0 |
| TOTAL | $25 | $25 | $6,102 | $6,294 | $6,589 |
| Total Assets | $671 | $769 | $6,689 | $7,403 | $8,321 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 151 | 155 | 63 | 838 | 969 |
| TOTAL | $151 | $155 | $63 | $1,138 | $969 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $151 | $155 | $63 | $1,138 | $969 |
| Shareholders' Equity | |||||
| Common Shares | 19,354 | 19,354 | 19,354 | 19,354 | 19,354 |
| Retained earnings | -20,679 | -21,611 | -16,226 | -16,684 | -15,413 |
| Other shareholders' equity | 1,846 | 2,872 | 3,499 | 3,595 | 3,412 |
| TOTAL | $520 | $615 | $6,626 | $6,265 | $7,353 |
| Total Liabilities And Equity | $671 | $769 | $6,689 | $7,403 | $8,321 |